![Christopher Reinhard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Reinhard
Chief Executive Officer at
Taxus Cardium Pharmaceuticals Group, Inc.
Profile
Christopher J.
Reinhard was the founder of Collateral Therapeutics, Inc., founded in 1996, where the title held was Chief Executive Officer in 2002.
Mr. Reinhard is the founder of Gene Biotherapeutics, Inc., founded in 2003, holding the title of Chief Executive Officer.
Former jobs include Chairman, President, CEO, CFO & Treasurer at Aries Ventures, Inc. from 2005 to 2006; Chief Executive Officer & Director at Post-Hypothermia Corp.
from 2006 to 2009; Chief Executive Officer & Director at To Go Brands, Inc. from 2012 to 2013; President & Chief Executive Officer at Tissue Repair Co. from 2006 to 2013; Executive Chairman at Artes Medical, Inc. from 2004 to 2008; Director at Ontro, Inc.; Managing Director & Vice President at The Henley Group, Inc. (New Hampshire); Vice President at IMED Corp; Vice President at Instrumentation Laboratory Co.; Vice President at Fisher Scientific Group, Inc. Education includes undergraduate and MBA degrees from Babson College.
Christopher Reinhard active positions
| Companies | Position | Start |
|---|---|---|
Taxus Cardium Pharmaceuticals Group, Inc.
 Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Chief Executive Officer | 2003-12-21 |
Former positions of Christopher Reinhard
| Companies | Position | End |
|---|---|---|
To Go Brands, Inc.
 To Go Brands, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets health products | Chief Executive Officer | 2013-10-31 |
Post-Hypothermia Corp.
 Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Manufactures and markets temperature modulation therapy devices | Chief Executive Officer | 2009-06-30 |
Artes Medical, Inc.
 Artes Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures, commercializes of injectable aesthetic products for dermatology and plastic surgery markets | Chairman | 2007-12-31 |
Aries Ventures, Inc.
 Aries Ventures, Inc. Financial ConglomeratesFinance Financial investment vehicle | Chief Executive Officer | 2006-01-22 |
Collateral Therapeutics, Inc.
 Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes non-surgical gene therapy products | Founder | 2002-07-02 |
Training of Christopher Reinhard
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
42
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Aries Ventures, Inc.
Aries Ventures, Inc. Financial ConglomeratesFinance Financial investment vehicle | Finance |
Ontro, Inc.
 Ontro, Inc. Miscellaneous ManufacturingProducer Manufacturing Develop integrated thermal containers | Producer Manufacturing |
Collateral Therapeutics, Inc.
Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes non-surgical gene therapy products | Commercial Services |
Tissue Repair Co.
 Tissue Repair Co. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops wound healing products for chronic wounds and aftercare | Health Technology |
IMED Corp
 IMED Corp Medical SpecialtiesHealth Technology Surgical & medical instruments | Health Technology |
Instrumentation Laboratory Co.
 Instrumentation Laboratory Co. Medical SpecialtiesHealth Technology Manufactures diagnostic products | Health Technology |
Artes Medical, Inc.
Artes Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures, commercializes of injectable aesthetic products for dermatology and plastic surgery markets | Health Technology |
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Post-Hypothermia Corp.
Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Manufactures and markets temperature modulation therapy devices | Health Technology |
Taxus Cardium Pharmaceuticals Group, Inc.
Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Health Technology |
The Henley Group, Inc. (New Hampshire)
 The Henley Group, Inc. (New Hampshire) Medical SpecialtiesHealth Technology Functions as an holding company through its subsidiaries manufactures laboratory equipment, aerospace and industrial parts | Health Technology |
To Go Brands, Inc.
To Go Brands, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets health products | Health Technology |
Fisher Scientific Group, Inc. |
- Stock Market
- Insiders
- Christopher Reinhard
